These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 16678669
21. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage]. Fernández-Gallego J, Martín MA, Alonso A, Toledo R. Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439 [No Abstract] [Full Text] [Related]
22. [Treatment of preoperative anemia in major orthopedic surgery]. Bisbe Vives E. Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():52-6. PubMed ID: 26320345 [Abstract] [Full Text] [Related]
24. Iron supplementation in renal anemia. Fishbane S. Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471 [Abstract] [Full Text] [Related]
25. [Use of human recombinant erythropoietin in children with cancer]. Guyot D, Margueritte G. Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072 [Abstract] [Full Text] [Related]
26. [Correction of anemia in renal insufficiency: what target?]. Drüeke TB. Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892 [No Abstract] [Full Text] [Related]
27. KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L. Am J Kidney Dis; 2013 Nov; 62(5):849-59. PubMed ID: 23891356 [Abstract] [Full Text] [Related]
28. L-carnitine supplementation in the dialysis population: are Australian patients missing out? Reuter SE, Faull RJ, Evans AM. Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095 [Abstract] [Full Text] [Related]
29. [Change of hemoglobin level: causes and consequences. Renal anemia]. Ryckelynck JP. Nephrol Ther; 2008 Oct; 4 Spec No 2():9-16. PubMed ID: 19000893 [No Abstract] [Full Text] [Related]
30. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease. Fishbane S. Blood Purif; 2007 Oct; 25(1):53-7. PubMed ID: 17170538 [Abstract] [Full Text] [Related]
33. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. J Nephrol; 2008 Oct; 21(2):236-42. PubMed ID: 18446719 [Abstract] [Full Text] [Related]
37. [Clinical practice guideline for anemia management in chronic kidney disease]. Croatian Society of Nephrology, Dialysis and Transplantation, Croatian Medical Association. Acta Med Croatica; 2009 Sep; 63 Suppl 1():78-88. PubMed ID: 20232557 [No Abstract] [Full Text] [Related]
38. [Diagnosis and therapy of renal anemia. Iron levels should be watched carefully: MMW Seminar on Anemia. 2]. Hörl WH. MMW Fortschr Med; 1999 Jun 17; 141(24):47-8. PubMed ID: 10468495 [No Abstract] [Full Text] [Related]
39. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Gonzalez-Porras JR, Colado E, Conde MP, Lopez T, Nieto MJ, Corral M. Transfus Med; 2009 Feb 17; 19(1):35-42. PubMed ID: 19302453 [Abstract] [Full Text] [Related]
40. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients. Kwan JT, Pratt RD, Epoetin Delta Study Group. Curr Med Res Opin; 2007 Feb 17; 23(2):307-11. PubMed ID: 17288685 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]